Skip to main content

Peer Review reports

From: Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study

Original Submission
19 Jul 2016 Submitted Original manuscript
7 Sep 2016 Reviewed Reviewer Report - Espen Benjaminsen
12 Sep 2016 Reviewed Reviewer Report - Kerstin Göbel
26 Oct 2016 Author responded Author comments - Takahiko Saida
Resubmission - Version 2
26 Oct 2016 Submitted Manuscript version 2
17 Nov 2016 Author responded Author comments - Takahiko Saida
Resubmission - Version 3
17 Nov 2016 Submitted Manuscript version 3
12 Dec 2016 Author responded Author comments - Takahiko Saida
Resubmission - Version 4
12 Dec 2016 Submitted Manuscript version 4
Publishing
11 Jan 2017 Editorially accepted
28 Jan 2017 Article published 10.1186/s12883-017-0794-5

You can find further information about peer review here.

Back to article page